Welcome to our dedicated page for Cra Intl news (Ticker: CRAI), a resource for investors and traders seeking the latest updates and insights on Cra Intl stock.
CRA International Inc. (CRAI), operating as Charles River Associates, is a globally recognized consulting firm specializing in providing expert advisory services in economic, financial, litigation, regulatory, and management consulting. Founded in 1965 and headquartered in Boston, Massachusetts, CRAI has established itself as a trusted partner for businesses, government agencies, and trade associations seeking objective and data-driven solutions to complex challenges.
Core Business Areas
CRAI's operations are structured around delivering high-value consulting services across several critical domains:
- Litigation and Regulatory Consulting: The company provides economic and financial analysis to support litigation and regulatory proceedings, assisting clients in navigating complex legal and compliance landscapes.
- Management Consulting: CRAI advises businesses on strategic and operational issues, helping them optimize performance, enhance efficiency, and achieve long-term goals.
- Financial Advisory: The firm offers expert guidance on financial matters, including valuation, risk management, and transaction advisory.
Global Reach and Industry Expertise
With offices spanning multiple countries, including the United States and the United Kingdom, CRAI serves a diverse clientele ranging from multinational corporations to government entities and trade associations. The firm's industry expertise is broad, covering sectors such as healthcare, energy, telecommunications, and financial services. This extensive knowledge base enables CRAI to tailor its consulting services to the specific needs of each client, ensuring actionable and impactful outcomes.
Revenue Model
CRAI primarily generates revenue through project-based engagements and long-term advisory retainers. Its business model relies on delivering bespoke solutions that address the unique challenges faced by its clients. By combining technical expertise with strategic insights, CRAI creates significant value, justifying its premium consulting fees.
Competitive Landscape
Operating in the highly competitive professional services industry, CRAI faces competition from global consulting giants such as McKinsey & Company, Boston Consulting Group, and specialized firms focusing on economic and financial consulting. CRAI differentiates itself through its unique blend of functional expertise and deep industry knowledge, as well as its commitment to providing objective, data-driven solutions.
Significance in the Industry
CRAI plays a pivotal role in addressing critical business and regulatory challenges. Its ability to provide rigorous analysis and strategic guidance makes it an indispensable partner for organizations navigating complex environments. By leveraging its global presence and multidisciplinary expertise, CRAI continues to be a key player in the consulting industry.
Charles River Associates (CRAI) announced that it will host a webcast for its second-quarter 2022 financial results on August 4, 2022, at 10:00 a.m. ET. The call will feature insights from CEO Paul Maleh, CFO Daniel Mahoney, and Chief Corporate Development Officer Chad Holmes. Investors can access the live webcast on CRA's Investor Relations page. Pre-call materials, including a press release and supplemental financial information, will be available online. An archived version of the event will be accessible for one year.
Charles River Associates (CRAI) has launched its innovative Healthcare Claims Analytics Platform (HCAP) at the World Orphan Drug Congress USA 2022 in Boston. This new modular analytics tool aims to enhance decision-making for clients by analyzing patient, healthcare practitioner, and healthcare organization data. Developed over 18 months by CRA's Life Sciences Practice, HCAP supports advanced analytics, clinical trial strategies, and market insights. CRA's commitment to innovation is evident in this launch, designed to meet the needs of biotech and pharmaceutical firms globally.
Charles River Associates (NASDAQ: CRAI) will participate in the 12th Annual East Coast IDEAS Investor Conference Virtual Event on June 22, 2022. The company’s leadership, including CEO Paul Maleh, CFO Daniel Mahoney, and Chief Corporate Development Officer Chad Holmes, will engage in virtual one-on-one meetings with investors. CRA specializes in economic, financial, and management consulting services, providing solutions for complex business and regulatory challenges. More information is available at www.crai.com.
Charles River Associates (NASDAQ: CRAI) announced its participation in the Sidoti & Company Summer Virtual Small Cap Conference on June 15, 2022. The Company’s Chairman and CEO, Paul Maleh, will present at 9:15 a.m. ET. A live webcast is available on the Company's investor relations website, allowing online attendees to submit questions for a virtual Q&A session. Additionally, Maleh, along with CFO Daniel Mahoney and Chad Holmes, the Chief Corporate Development Officer, will hold virtual one-on-one meetings with investors.
Charles River Associates (NASDAQ: CRAI) has appointed David Cowen as Vice President in their Forensic Services practice. With over 25 years of experience in digital forensics and cybersecurity, Cowen is recognized for his expertise in addressing fraud, cybercrime, and compliance issues. He previously co-founded a consulting firm acquired by a Big Four accounting firm, emphasizing the company's commitment to enhancing its forensic capabilities. CRA's Forensic Services team is ISO 27001:2013 certified, ensuring high standards in information security.
Charles River Associates (NASDAQ: CRAI) has appointed Joshua Gans as a Senior Consultant in the Antitrust & Competition Economics Practice at its Toronto office. Gans, a distinguished professor from the University of Toronto, brings extensive expertise in innovation competition and economics, particularly concerning digital markets and AI. His appointment aims to enhance CRA’s analytical capabilities in providing economic analysis and testimony in global antitrust matters. Gans has authored numerous publications and is recognized for his impactful contributions to regulatory discussions.
Charles River Associates (NASDAQ: CRAI) reported record quarterly revenue of $148.4 million for Q1 fiscal 2022, marking a 1.3% year-over-year increase. Net income rose 8.8% to $11.4 million, with earnings per diluted share increasing 13.4% to $1.52. The company also reaffirmed its full-year revenue guidance of $585 million to $605 million. Additionally, CRA returned $7.4 million to shareholders through dividends and share repurchases. The strong performance was supported by double-digit revenue growth across five business practices.
Charles River Associates (NASDAQ: CRAI) has declared a quarterly cash dividend of $0.31 per common share, scheduled for payment on June 10, 2022. Shareholders on record as of May 31, 2022 will receive this dividend. The company expresses its intent to continue paying quarterly dividends, though the timing and amounts are subject to the Board's discretion. This announcement reflects CRAI's commitment to returning value to shareholders amid a competitive consulting landscape.
Charles River Associates (CRAI) announced a live webcast for its first-quarter 2022 financial results conference call on May 5, 2022, at 10:00 a.m. ET. The call will be hosted by CEO Paul Maleh, CFO Daniel Mahoney, and Chief Corporate Development Officer Chad Holmes. Investors can access the call via CRA’s website or by phone. A press release detailing the financial results will be posted beforehand, with archived access available for one year. CRA specializes in economic, financial, and management consulting, providing insights into strategic business challenges.
FAQ
What is the current stock price of Cra Intl (CRAI)?
What is the market cap of Cra Intl (CRAI)?
What does CRA International Inc (CRAI) specialize in?
Who are CRAI's typical clients?
How does CRAI generate revenue?
What industries does CRAI serve?
How does CRAI differentiate itself from competitors?
Where is CRAI headquartered, and does it operate internationally?
What role does CRAI play in regulatory consulting?
What are CRAI's core business areas?
